{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tissue+sample+for+genetic+testing&page=3", "query": { "intervention": "Tissue sample for genetic testing", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 78, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tissue+sample+for+genetic+testing&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tissue+sample+for+genetic+testing&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-09T05:12:57.874Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03155620", "title": "Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Malignant Solid Neoplasm", "Ann Arbor Stage III Non-Hodgkin Lymphoma", "Ann Arbor Stage IV Non-Hodgkin Lymphoma", "Histiocytic Sarcoma", "Juvenile Xanthogranuloma", "Langerhans Cell Histiocytosis", "Malignant Glioma", "Recurrent Childhood Rhabdomyosarcoma", "Recurrent Ependymoma", "Recurrent Ewing Sarcoma", "Recurrent Glioma", "Recurrent Hepatoblastoma", "Recurrent Langerhans Cell Histiocytosis", "Recurrent Malignant Germ Cell Tumor", "Recurrent Malignant Solid Neoplasm", "Recurrent Medulloblastoma", "Recurrent Neuroblastoma", "Recurrent Non-Hodgkin Lymphoma", "Recurrent Osteosarcoma", "Recurrent Peripheral Primitive Neuroectodermal Tumor", "Recurrent Primary Central Nervous System Neoplasm", "Recurrent Rhabdoid Tumor", "Recurrent Soft Tissue Sarcoma", "Refractory Ewing Sarcoma", "Refractory Glioma", "Refractory Hepatoblastoma", "Refractory Langerhans Cell Histiocytosis", "Refractory Malignant Germ Cell Tumor", "Refractory Malignant Solid Neoplasm", "Refractory Medulloblastoma", "Refractory Neuroblastoma", "Refractory Non-Hodgkin Lymphoma", "Refractory Osteosarcoma", "Refractory Peripheral Primitive Neuroectodermal Tumor", "Refractory Primary Central Nervous System Neoplasm", "Refractory Rhabdoid Tumor", "Refractory Rhabdomyosarcoma", "Rhabdoid Tumor", "Stage III Osteosarcoma AJCC v7", "Stage III Soft Tissue Sarcoma AJCC v7", "Stage IV Osteosarcoma AJCC v7", "Stage IV Soft Tissue Sarcoma AJCC v7", "Stage IVA Osteosarcoma AJCC v7", "Stage IVB Osteosarcoma AJCC v7", "Wilms Tumor" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration and Biopsy", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Ensartinib", "type": "DRUG" }, { "name": "Erdafitinib", "type": "DRUG" }, { "name": "Ivosidenib", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Larotrectinib Sulfate", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Mutation Carrier Screening", "type": "PROCEDURE" }, { "name": "Olaparib", "type": "DRUG" }, { "name": "Palbociclib", "type": "DRUG" }, { "name": "Pharmacological Study", "type": "OTHER" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Radionuclide Imaging", "type": "PROCEDURE" }, { "name": "Samotolisib", "type": "DRUG" }, { "name": "Selpercatinib", "type": "DRUG" }, { "name": "Selumetinib Sulfate", "type": "DRUG" }, { "name": "Tazemetostat", "type": "DRUG" }, { "name": "Tipifarnib", "type": "DRUG" }, { "name": "Ulixertinib", "type": "DRUG" }, { "name": "Vemurafenib", "type": "DRUG" }, { "name": "X-Ray Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "21 Years", "sex": "ALL", "summary": "12 Months to 21 Years" }, "enrollment_count": 1377, "start_date": "2017-07-31", "completion_date": "2027-01-06", "has_results": true, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 168, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Mesa, Arizona + 126 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03155620" }, { "nct_id": "NCT06482073", "title": "Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lung Carcinoma", "Metastatic Malignant Neoplasm in the Lung" ], "interventions": [ { "name": "Non-Interventional Study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2024-06-24", "completion_date": "2027-07-01", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06482073" }, { "nct_id": "NCT05380557", "title": "ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pancreatic Adenocarcinoma", "Pancreatic Cancer", "Resectable Pancreatic Cancer" ], "interventions": [ { "name": "Germline genetic testing", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Invitae Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2021-08-23", "completion_date": "2022-09-06", "has_results": false, "last_update_posted_date": "2022-12-07", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05380557" }, { "nct_id": "NCT02780128", "title": "Next Generation Personalized Neuroblastoma Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neuroblastoma", "Cancer" ], "interventions": [ { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Next Generation Sequencing", "type": "GENETIC" }, { "name": "Tumor Scans", "type": "PROCEDURE" }, { "name": "Bone marrow Tests", "type": "PROCEDURE" }, { "name": "Physical Exam", "type": "OTHER" }, { "name": "Eye Exam", "type": "OTHER" }, { "name": "Labs", "type": "OTHER" }, { "name": "Pregnancy Test", "type": "OTHER" }, { "name": "Interviews", "type": "BEHAVIORAL" }, { "name": "ECG", "type": "OTHER" }, { "name": "Echocardiogram", "type": "OTHER" }, { "name": "Ribociclib", "type": "DRUG" }, { "name": "Ceritinib", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "GENETIC", "OTHER", "BEHAVIORAL", "DRUG" ], "sponsor": "Yael P Mosse", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 66, "start_date": "2016-07", "completion_date": "2022-08", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02780128" }, { "nct_id": "NCT06441955", "title": "Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COVID-19, Long Haul" ], "interventions": [ { "name": "Ritonavir-Boosted Nirmatrelvir (Paxlovid)", "type": "DRUG" }, { "name": "Physiological Evaluation", "type": "DIAGNOSTIC_TEST" }, { "name": "Moderna COVID-19 Vaccine", "type": "BIOLOGICAL" }, { "name": "Biopsychological", "type": "BEHAVIORAL" }, { "name": "Behavioral (e.g., Psychotherapy, Lifestyle Counseling)", "type": "BEHAVIORAL" }, { "name": "Genetic (including gene transfer, stem cell and recombinant DNA)", "type": "GENETIC" }, { "name": "Multidisciplinary approach", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "BIOLOGICAL", "BEHAVIORAL", "GENETIC", "COMBINATION_PRODUCT" ], "sponsor": "Well- Konnect Healthcare Services and Research Firm", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2024-03-01", "completion_date": "2030-09-30", "has_results": false, "last_update_posted_date": "2024-11-27", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06441955" }, { "nct_id": "NCT00363779", "title": "Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Large Granular Lymphocytic Leukemia", "LGL Leukemia" ], "interventions": [ { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Gene expression analysis", "type": "GENETIC" }, { "name": "Microarray analysis", "type": "GENETIC" }, { "name": "Laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "GENETIC", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2006-06", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2015-07-21", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00363779" }, { "nct_id": "NCT04600466", "title": "Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Gastric Cancer" ], "interventions": [ { "name": "Molecular testing for all participants.", "type": "OTHER" }, { "name": "Germline Testing", "type": "OTHER" }, { "name": "Survey", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 129, "start_date": "2021-01-22", "completion_date": "2025-06-06", "has_results": false, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04600466" }, { "nct_id": "NCT04857528", "title": "Detecting HPV DNA in Anal and Cervical Cancers", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cervical Cancer", "Anal Cancer", "HPV-Related Anal Squamous Cell Carcinoma", "HPV-Related Cervical Carcinoma", "HPV-Related Carcinoma", "Uterine Cervical Cancer" ], "interventions": [ { "name": "Radiation Treatment With or Without Chemotherapy", "type": "RADIATION" }, { "name": "Blood Sample Collection", "type": "OTHER" }, { "name": "HPV Genotyping (HPV DNA Test)", "type": "DIAGNOSTIC_TEST" }, { "name": "Testing Archival Tumor Tissue", "type": "DIAGNOSTIC_TEST" }, { "name": "Physical Exam", "type": "OTHER" }, { "name": "Positron Emission Tomography Scan (PET Scan)/ Computed Tomography Scan (CT Scan)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "RADIATION", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2020-10-06", "completion_date": "2027-11-15", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 2, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04857528" }, { "nct_id": "NCT00542373", "title": "Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Erythroplakia", "Fanconi Anemia", "Lichen Planus", "Oral Cavity and Lip Precancerous Condition", "Oral Cavity Leukoplakia", "Oral Neoplasm", "Premalignant Lesion", "Tobacco Use Disorder" ], "interventions": [ { "name": "Cytology Specimen Collection Procedure", "type": "OTHER" }, { "name": "Diagnostic Microscopy", "type": "PROCEDURE" }, { "name": "Diagnostic Procedure", "type": "PROCEDURE" }, { "name": "Fluorescence Imaging", "type": "PROCEDURE" }, { "name": "Fluorescence Spectroscopy", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 338, "start_date": "2007-08-27", "completion_date": "2027-04-30", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00542373" }, { "nct_id": "NCT04541654", "title": "Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Li-Fraumeni Syndrome", "TP53 Gene Mutation", "Hereditary Cancer Syndrome", "Clonal Hematopoiesis", "Mosaicism" ], "interventions": [ { "name": "Data and Specimen Collection", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1500, "start_date": "2020-09-15", "completion_date": "2032-12-31", "has_results": false, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-11-09T05:12:57.874Z", "location_count": 3, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04541654" } ] }